The Pharmacological TAILS of Matrix Metalloproteinases and Their Inhibitors

Matrix metalloproteinases (MMPs) have been demonstrated to have both detrimental and protective functions in inflammatory diseases. Several MMP inhibitors, with the exception of Periostat<sup>®</sup>, have failed in Phase III clinical trials. As an alternative strategy, recent efforts ha...

Full description

Bibliographic Details
Published in:Pharmaceuticals
Main Authors: Nabangshu Das, Colette Benko, Sean E. Gill, Antoine Dufour
Format: Article
Language:English
Published: MDPI AG 2020-12-01
Subjects:
matrix metalloproteinases (MMPs), protease
tissue inhibitors of metalloproteinases (TIMPs), exosite
small molecule inhibitors
monoclonal antibodies
proteomics
N-terminomics
Online Access:https://www.mdpi.com/1424-8247/14/1/31

Internet

https://www.mdpi.com/1424-8247/14/1/31

Similar Items